世界の無菌注射剤市場予測 2020年-2025年

【英語タイトル】Global Sterile Injectable Drugs Market Growth 2020-2025

LP Informationが出版した調査資料(LPI21MA11872)・商品コード:LPI21MA11872
・発行会社(調査会社):LP Information
・発行日:2021年1月(※2024年版があります。お問い合わせください)
・ページ数:137
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「無菌注射剤の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、サイトカイン、インスリン、ペプチドホルモン、ワクチン、免疫グロブリン、血液因子、ペプチド抗生物質、その他など、用途別には、がん、糖尿病、心血管疾患、筋骨格系、中枢神経系、感染症、その他などに区分してまとめた調査レポートです。無菌注射剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・無菌注射剤の世界市場概要(サマリー)
・無菌注射剤の企業別販売量・売上
・無菌注射剤の企業別市場シェア
・無菌注射剤の世界市場規模 2015年-2020年:種類別(サイトカイン、インスリン、ペプチドホルモン、ワクチン、免疫グロブリン、血液因子、ペプチド抗生物質、その他)
・無菌注射剤の世界市場規模 2015年-2020年:用途別(がん、糖尿病、心血管疾患、筋骨格系、中枢神経系、感染症、その他)
・無菌注射剤の米州市場規模(アメリカ、カナダ、メキシコなど)
・無菌注射剤のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・無菌注射剤の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・無菌注射剤の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・無菌注射剤市場の成長要因・課題・動向
・無菌注射剤の世界市場予測 2021年-2025年
・無菌注射剤の米州市場予測(アメリカ、カナダ、メキシコなど)
・無菌注射剤のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・無菌注射剤の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・無菌注射剤の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・無菌注射剤の世界市場予測:種類別(サイトカイン、インスリン、ペプチドホルモン、ワクチン、免疫グロブリン、血液因子、ペプチド抗生物質、その他)
・無菌注射剤の世界市場予測:用途別(がん、糖尿病、心血管疾患、筋骨格系、中枢神経系、感染症、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Sterile Injectable Drugs market will register a 5.4%% CAGR in terms of revenue, the global market size will reach $ 4113.6 million by 2025, from $ 3333.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Sterile Injectable Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Injectable Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Sterile Injectable Drugs, covering the supply chain analysis, impact assessment to the Sterile Injectable Drugs market size growth rate in several scenarios, and the measures to be undertaken by Sterile Injectable Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Cytokines
Insulin
Peptide hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide antibiotics
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baxter International
Sanofi
AstraZeneca
Merck
GlaxoSmithKline
GILEAD SCIENCES
Novartis
Johnson & Johnson Services
Pfizer

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Sterile Injectable Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Sterile Injectable Drugs market by identifying its various subsegments.
Focuses on the key global Sterile Injectable Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Sterile Injectable Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Sterile Injectable Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sterile Injectable Drugs Consumption 2015-2025
2.1.2 Sterile Injectable Drugs Consumption CAGR by Region
2.2 Sterile Injectable Drugs Segment by Type
2.2.1 Cytokines
2.2.2 Insulin
2.2.3 Peptide hormones
2.2.4 Vaccines
2.2.5 Immunoglobulins
2.2.6 Blood Factors
2.2.7 Peptide antibiotics
2.2.8 Others
2.3 Sterile Injectable Drugs Consumption by Type
2.3.1 Global Sterile Injectable Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Sterile Injectable Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Sterile Injectable Drugs Sale Price by Type (2015-2020)
2.4 Sterile Injectable Drugs Segment by Application
2.4.1 Cancer
2.4.2 Diabetes
2.4.3 Cardiovascular Diseases
2.4.4 Musculoskeletal
2.4.5 CNS
2.4.6 Infections
2.4.7 Others
2.5 Sterile Injectable Drugs Consumption by Application
2.5.1 Global Sterile Injectable Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Sterile Injectable Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Sterile Injectable Drugs Sale Price by Type (2015-2020)

3 Global Sterile Injectable Drugs by Company
3.1 Global Sterile Injectable Drugs Sales Market Share by Company
3.1.1 Global Sterile Injectable Drugs Sales by Company (2018-2020)
3.1.2 Global Sterile Injectable Drugs Sales Market Share by Company (2018-2020)
3.2 Global Sterile Injectable Drugs Revenue Market Share by Company
3.2.1 Global Sterile Injectable Drugs Revenue by Company (2018-2020)
3.2.2 Global Sterile Injectable Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Sterile Injectable Drugs Sale Price by Company
3.4 Global Sterile Injectable Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Sterile Injectable Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Sterile Injectable Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Sterile Injectable Drugs by Regions
4.1 Sterile Injectable Drugs by Regions
4.2 Americas Sterile Injectable Drugs Consumption Growth
4.3 APAC Sterile Injectable Drugs Consumption Growth
4.4 Europe Sterile Injectable Drugs Consumption Growth
4.5 Middle East & Africa Sterile Injectable Drugs Consumption Growth

5 Americas
5.1 Americas Sterile Injectable Drugs Consumption by Countries
5.1.1 Americas Sterile Injectable Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Sterile Injectable Drugs Value by Countries (2015-2020)
5.2 Americas Sterile Injectable Drugs Consumption by Type
5.3 Americas Sterile Injectable Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Sterile Injectable Drugs Consumption by Regions
6.1.1 APAC Sterile Injectable Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Sterile Injectable Drugs Value by Regions (2015-2020)
6.2 APAC Sterile Injectable Drugs Consumption by Type
6.3 APAC Sterile Injectable Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Sterile Injectable Drugs by Countries
7.1.1 Europe Sterile Injectable Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Sterile Injectable Drugs Value by Countries (2015-2020)
7.2 Europe Sterile Injectable Drugs Consumption by Type
7.3 Europe Sterile Injectable Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Sterile Injectable Drugs by Countries
8.1.1 Middle East & Africa Sterile Injectable Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Sterile Injectable Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Sterile Injectable Drugs Consumption by Type
8.3 Middle East & Africa Sterile Injectable Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Sterile Injectable Drugs Distributors
10.3 Sterile Injectable Drugs Customer

11 Global Sterile Injectable Drugs Market Forecast
11.1 Global Sterile Injectable Drugs Consumption Forecast (2021-2025)
11.2 Global Sterile Injectable Drugs Forecast by Regions
11.2.1 Global Sterile Injectable Drugs Forecast by Regions (2021-2025)
11.2.2 Global Sterile Injectable Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Sterile Injectable Drugs Forecast by Type
11.8 Global Sterile Injectable Drugs Forecast by Application

12 Key Players Analysis
12.1 Baxter International
12.1.1 Company Information
12.1.2 Sterile Injectable Drugs Product Offered
12.1.3 Baxter International Sterile Injectable Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Baxter International Latest Developments
12.2 Sanofi
12.2.1 Company Information
12.2.2 Sterile Injectable Drugs Product Offered
12.2.3 Sanofi Sterile Injectable Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sanofi Latest Developments
12.3 AstraZeneca
12.3.1 Company Information
12.3.2 Sterile Injectable Drugs Product Offered
12.3.3 AstraZeneca Sterile Injectable Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 AstraZeneca Latest Developments
12.4 Merck
12.4.1 Company Information
12.4.2 Sterile Injectable Drugs Product Offered
12.4.3 Merck Sterile Injectable Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Merck Latest Developments
12.5 GlaxoSmithKline
12.5.1 Company Information
12.5.2 Sterile Injectable Drugs Product Offered
12.5.3 GlaxoSmithKline Sterile Injectable Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 GlaxoSmithKline Latest Developments
12.6 GILEAD SCIENCES
12.6.1 Company Information
12.6.2 Sterile Injectable Drugs Product Offered
12.6.3 GILEAD SCIENCES Sterile Injectable Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 GILEAD SCIENCES Latest Developments
12.7 Novartis
12.7.1 Company Information
12.7.2 Sterile Injectable Drugs Product Offered
12.7.3 Novartis Sterile Injectable Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Novartis Latest Developments
12.8 Johnson & Johnson Services
12.8.1 Company Information
12.8.2 Sterile Injectable Drugs Product Offered
12.8.3 Johnson & Johnson Services Sterile Injectable Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Johnson & Johnson Services Latest Developments
12.9 Pfizer
12.9.1 Company Information
12.9.2 Sterile Injectable Drugs Product Offered
12.9.3 Pfizer Sterile Injectable Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Pfizer Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Sterile Injectable Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Cytokines
Table 5. Major Players of Insulin
Table 6. Major Players of Peptide hormones
Table 7. Major Players of Vaccines
Table 8. Major Players of Immunoglobulins
Table 9. Major Players of Blood Factors
Table 10. Major Players of Peptide antibiotics
Table 11. Major Players of Others
Table 12. Global Consumption Sales by Type (2015-2020)
Table 13. Global Sterile Injectable Drugs Consumption Market Share by Type (2015-2020)
Table 14. Global Sterile Injectable Drugs Revenue by Type (2015-2020) ($ million)
Table 15. Global Sterile Injectable Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 16. Global Sterile Injectable Drugs Sale Price by Type (2015-2020)
Table 17. Global Consumption Sales by Application (2015-2020)
Table 18. Global Sterile Injectable Drugs Consumption Market Share by Application (2015-2020)
Table 19. Global Sterile Injectable Drugs Value by Application (2015-2020)
Table 20. Global Sterile Injectable Drugs Value Market Share by Application (2015-2020)
Table 21. Global Sterile Injectable Drugs Sale Price by Application (2015-2020)
Table 22. Global Sterile Injectable Drugs Sales by Company (2017-2019) (K Units)
Table 23. Global Sterile Injectable Drugs Sales Market Share by Company (2017-2019)
Table 24. Global Sterile Injectable Drugs Revenue by Company (2017-2019) ($ Millions)
Table 25. Global Sterile Injectable Drugs Revenue Market Share by Company (2017-2019)
Table 26. Global Sterile Injectable Drugs Sale Price by Company (2017-2019)
Table 27. Global Sterile Injectable Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 28. Players Sterile Injectable Drugs Products Offered
Table 29. Sterile Injectable Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 30. Global Sterile Injectable Drugs Consumption by Regions 2015-2020 (K Units)
Table 31. Global Sterile Injectable Drugs Consumption Market Share by Regions 2015-2020
Table 32. Global Sterile Injectable Drugs Value by Regions 2015-2020 ($ Millions)
Table 33. Global Sterile Injectable Drugs Value Market Share by Regions 2015-2020
Table 34. Americas Sterile Injectable Drugs Consumption by Countries (2015-2020) (K Units)
Table 35. Americas Sterile Injectable Drugs Consumption Market Share by Countries (2015-2020)
Table 36. Americas Sterile Injectable Drugs Value by Countries (2015-2020) ($ Millions)
Table 37. Americas Sterile Injectable Drugs Value Market Share by Countries (2015-2020)
Table 38. Americas Sterile Injectable Drugs Consumption by Type (2015-2020) (K Units)
Table 39. Americas Sterile Injectable Drugs Consumption Market Share by Type (2015-2020)
Table 40. Americas Sterile Injectable Drugs Consumption by Application (2015-2020) (K Units)
Table 41. Americas Sterile Injectable Drugs Consumption Market Share by Application (2015-2020)
Table 42. APAC Sterile Injectable Drugs Consumption by Countries (2015-2020) (K Units)
Table 43. APAC Sterile Injectable Drugs Consumption Market Share by Countries (2015-2020)
Table 44. APAC Sterile Injectable Drugs Value by Regions (2015-2020) ($ Millions)
Table 45. APAC Sterile Injectable Drugs Value Market Share by Regions (2015-2020)
Table 46. APAC Sterile Injectable Drugs Consumption by Type (2015-2020) (K Units)
Table 47. APAC Sterile Injectable Drugs Consumption Market Share by Type (2015-2020)
Table 48. APAC Sterile Injectable Drugs Consumption by Application (2015-2020) (K Units)
Table 49. APAC Sterile Injectable Drugs Consumption Market Share by Application (2015-2020)
Table 50. Europe Sterile Injectable Drugs Consumption by Countries (2015-2020) (K Units)
Table 51. Europe Sterile Injectable Drugs Consumption Market Share by Countries (2015-2020)
Table 52. Europe Sterile Injectable Drugs Value by Countries (2015-2020) ($ Millions)
Table 53. Europe Sterile Injectable Drugs Value Market Share by Countries (2015-2020)
Table 54. Europe Sterile Injectable Drugs Consumption by Type (2015-2020) (K Units)
Table 55. Europe Sterile Injectable Drugs Consumption Market Share by Type (2015-2020)
Table 56. Europe Sterile Injectable Drugs Consumption by Application (2015-2020) (K Units)
Table 57. Europe Sterile Injectable Drugs Consumption Market Share by Application (2015-2020)
Table 58. Middle East & Africa Sterile Injectable Drugs Consumption by Countries (2015-2020) (K Units)
Table 59. Middle East & Africa Sterile Injectable Drugs Consumption Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Sterile Injectable Drugs Value by Countries (2015-2020) ($ Millions)
Table 61. Middle East & Africa Sterile Injectable Drugs Value Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Sterile Injectable Drugs Consumption by Type (2015-2020) (K Units)
Table 63. Middle East & Africa Sterile Injectable Drugs Consumption Market Share by Type (2015-2020)
Table 64. Middle East & Africa Sterile Injectable Drugs Consumption by Application (2015-2020) (K Units)
Table 65. Middle East & Africa Sterile Injectable Drugs Consumption Market Share by Application (2015-2020)
Table 66. Sterile Injectable Drugs Distributors List
Table 67. Sterile Injectable Drugs Customer List
Table 68. Global Sterile Injectable Drugs Consumption Forecast by Countries (2021-2025) (K Units)
Table 69. Global Sterile Injectable Drugs Consumption Market Forecast by Regions
Table 70. Global Sterile Injectable Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 71. Global Sterile Injectable Drugs Value Market Share Forecast by Regions
Table 72. Global Sterile Injectable Drugs Consumption Forecast by Type (2021-2025) (K Units)
Table 73. Global Sterile Injectable Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 74. Global Sterile Injectable Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 75. Global Sterile Injectable Drugs Value Market Share Forecast by Type (2021-2025)
Table 76. Global Sterile Injectable Drugs Consumption Forecast by Application (2021-2025) (K Units)
Table 77. Global Sterile Injectable Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 78. Global Sterile Injectable Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 79. Global Sterile Injectable Drugs Value Market Share Forecast by Application (2021-2025)
Table 80. Baxter International Product Offered
Table 81. Baxter International Sterile Injectable Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Baxter International Main Business
Table 83. Baxter International Latest Developments
Table 84. Baxter International Basic Information, Company Total Revenue (in $ million), Sterile Injectable Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Sanofi Product Offered
Table 86. Sanofi Sterile Injectable Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Sanofi Main Business
Table 88. Sanofi Latest Developments
Table 89. Sanofi Basic Information, Company Total Revenue (in $ million), Sterile Injectable Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. AstraZeneca Product Offered
Table 91. AstraZeneca Sterile Injectable Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. AstraZeneca Main Business
Table 93. AstraZeneca Latest Developments
Table 94. AstraZeneca Basic Information, Company Total Revenue (in $ million), Sterile Injectable Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck Product Offered
Table 96. Merck Sterile Injectable Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Merck Main Business
Table 98. Merck Latest Developments
Table 99. Merck Basic Information, Company Total Revenue (in $ million), Sterile Injectable Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. GlaxoSmithKline Product Offered
Table 101. GlaxoSmithKline Sterile Injectable Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. GlaxoSmithKline Main Business
Table 103. GlaxoSmithKline Latest Developments
Table 104. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Sterile Injectable Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. GILEAD SCIENCES Product Offered
Table 106. GILEAD SCIENCES Sterile Injectable Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 107. GILEAD SCIENCES Main Business
Table 108. GILEAD SCIENCES Latest Developments
Table 109. GILEAD SCIENCES Basic Information, Company Total Revenue (in $ million), Sterile Injectable Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Novartis Product Offered
Table 111. Novartis Basic Information, Company Total Revenue (in $ million), Sterile Injectable Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. Novartis Sterile Injectable Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 115. Johnson & Johnson Services Product Offered
Table 116. Johnson & Johnson Services Sterile Injectable Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Johnson & Johnson Services Main Business
Table 118. Johnson & Johnson Services Latest Developments
Table 119. Johnson & Johnson Services Basic Information, Company Total Revenue (in $ million), Sterile Injectable Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Product Offered
Table 121. Pfizer Sterile Injectable Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Pfizer Basic Information, Company Total Revenue (in $ million), Sterile Injectable Drugs Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Sterile Injectable Drugs
Figure 2. Sterile Injectable Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Sterile Injectable Drugs Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Sterile Injectable Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Cytokines
Figure 7. Product Picture of Insulin
Figure 8. Product Picture of Peptide hormones
Figure 9. Product Picture of Vaccines
Figure 10. Product Picture of Immunoglobulins
Figure 11. Product Picture of Blood Factors
Figure 12. Product Picture of Peptide antibiotics
Figure 13. Product Picture of Others
Figure 14. Global Sterile Injectable Drugs Consumption Market Share by Type (2015-2020)
Figure 15. Global Sterile Injectable Drugs Value Market Share by Type (2015-2020)
Figure 16. Sterile Injectable Drugs Consumed in Cancer
Figure 17. Global Sterile Injectable Drugs Market: Cancer (2015-2020) (K Units)
Figure 18. Global Sterile Injectable Drugs Market: Cancer (2015-2020) ($ Millions)
Figure 19. Sterile Injectable Drugs Consumed in Diabetes
Figure 20. Global Sterile Injectable Drugs Market: Diabetes (2015-2020) (K Units)
Figure 21. Global Sterile Injectable Drugs Market: Diabetes (2015-2020) ($ Millions)
Figure 22. Sterile Injectable Drugs Consumed in Cardiovascular Diseases
Figure 23. Global Sterile Injectable Drugs Market: Cardiovascular Diseases (2015-2020) (K Units)
Figure 24. Global Sterile Injectable Drugs Market: Cardiovascular Diseases (2015-2020) ($ Millions)
Figure 25. Sterile Injectable Drugs Consumed in Musculoskeletal
Figure 26. Global Sterile Injectable Drugs Market: Musculoskeletal (2015-2020) (K Units)
Figure 27. Global Sterile Injectable Drugs Market: Musculoskeletal (2015-2020) ($ Millions)
Figure 28. Sterile Injectable Drugs Consumed in CNS
Figure 29. Global Sterile Injectable Drugs Market: CNS (2015-2020) (K Units)
Figure 30. Global Sterile Injectable Drugs Market: CNS (2015-2020) ($ Millions)
Figure 31. Sterile Injectable Drugs Consumed in Infections
Figure 32. Sterile Injectable Drugs Consumed in Others
Figure 33. Global Sterile Injectable Drugs Consumption Market Share by Application (2015-2020)
Figure 34. Global Sterile Injectable Drugs Value Market Share by Application (2015-2020)
Figure 35. Global Sterile Injectable Drugs Sales Market Share by Company in 2017
Figure 36. Global Sterile Injectable Drugs Sales Market Share by Company in 2019
Figure 37. Global Sterile Injectable Drugs Revenue Market Share by Company in 2017
Figure 38. Global Sterile Injectable Drugs Revenue Market Share by Company in 2019
Figure 39. Global Sterile Injectable Drugs Sale Price by Company in 2019
Figure 40. Global Sterile Injectable Drugs Consumption Market Share by Regions 2015-2020
Figure 41. Global Sterile Injectable Drugs Value Market Share by Regions 2015-2020
Figure 42. Americas Sterile Injectable Drugs Consumption 2015-2020 (K Units)
Figure 43. Americas Sterile Injectable Drugs Value 2015-2020 ($ Millions)
Figure 44. APAC Sterile Injectable Drugs Consumption 2015-2020 (K Units)
Figure 45. APAC Sterile Injectable Drugs Value 2015-2020 ($ Millions)
Figure 46. Europe Sterile Injectable Drugs Consumption 2015-2020 (K Units)
Figure 47. Europe Sterile Injectable Drugs Value 2015-2020 ($ Millions)
Figure 48. Middle East & Africa Sterile Injectable Drugs Consumption 2015-2020 (K Units)
Figure 49. Middle East & Africa Sterile Injectable Drugs Value 2015-2020 ($ Millions)
Figure 50. Americas Sterile Injectable Drugs Consumption Market Share by Countries in 2019
Figure 51. Americas Sterile Injectable Drugs Value Market Share by Countries in 2019
Figure 52. Americas Sterile Injectable Drugs Consumption Market Share by Type in 2019
Figure 53. Americas Sterile Injectable Drugs Consumption Market Share by Application in 2019
Figure 54. United States Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 55. United States Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. Canada Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 57. Canada Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 58. Mexico Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 59. Mexico Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. APAC Sterile Injectable Drugs Consumption Market Share by Countries in 2019
Figure 61. APAC Sterile Injectable Drugs Value Market Share by Regions in 2019
Figure 62. APAC Sterile Injectable Drugs Consumption Market Share by Type in 2019
Figure 63. APAC Sterile Injectable Drugs Consumption Market Share by Application in 2019
Figure 64. China Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 65. China Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 66. Japan Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 67. Japan Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. Korea Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 69. Korea Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. Southeast Asia Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 71. Southeast Asia Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. India Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 73. India Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 74. Australia Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 75. Australia Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 76. Europe Sterile Injectable Drugs Consumption Market Share by Countries in 2019
Figure 77. Europe Sterile Injectable Drugs Value Market Share by Countries in 2019
Figure 78. Europe Sterile Injectable Drugs Consumption Market Share by Type in 2019
Figure 79. Europe Sterile Injectable Drugs Consumption Market Share by Application in 2019
Figure 80. Germany Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 81. Germany Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. France Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 83. France Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. UK Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 85. UK Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. Italy Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 87. Italy Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 88. Russia Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 89. Russia Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 90. Middle East & Africa Sterile Injectable Drugs Consumption Market Share by Countries in 2019
Figure 91. Middle East & Africa Sterile Injectable Drugs Value Market Share by Countries in 2019
Figure 92. Middle East & Africa Sterile Injectable Drugs Consumption Market Share by Type in 2019
Figure 93. Middle East & Africa Sterile Injectable Drugs Consumption Market Share by Application in 2019
Figure 94. Egypt Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 95. Egypt Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 96. South Africa Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 97. South Africa Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 98. Israel Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 99. Israel Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 100. Turkey Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 101. Turkey Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 102. GCC Countries Sterile Injectable Drugs Consumption Growth 2015-2020 (K Units)
Figure 103. GCC Countries Sterile Injectable Drugs Value Growth 2015-2020 ($ Millions)
Figure 104. Global Sterile Injectable Drugs Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 105. Global Sterile Injectable Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 106. Americas Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 107. Americas Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 108. APAC Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 109. APAC Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 110. Europe Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 111. Europe Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 112. Middle East & Africa Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 113. Middle East & Africa Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 114. United States Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 115. United States Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 116. Canada Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 117. Canada Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 118. Mexico Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 119. Mexico Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 120. Brazil Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 121. Brazil Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 122. China Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 123. China Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 124. Japan Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 125. Japan Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 126. Korea Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 127. Korea Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 128. Southeast Asia Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 129. Southeast Asia Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 130. India Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 131. India Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 132. Australia Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 133. Australia Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 134. Germany Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 135. Germany Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 136. France Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 137. France Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 138. UK Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 139. UK Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 140. Italy Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 141. Italy Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 142. Russia Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 143. Russia Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 144. Spain Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 145. Spain Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 146. Egypt Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 147. Egypt Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 148. South Africa Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 149. South Africa Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 150. Israel Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 151. Israel Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 152. Turkey Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 153. Turkey Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 154. GCC Countries Sterile Injectable Drugs Consumption 2021-2025 (K Units)
Figure 155. GCC Countries Sterile Injectable Drugs Value 2021-2025 ($ Millions)
Figure 156. Baxter International Sterile Injectable Drugs Market Share (2018-2020)
Figure 157. Sanofi Sterile Injectable Drugs Market Share (2018-2020)
Figure 158. AstraZeneca Sterile Injectable Drugs Market Share (2018-2020)
Figure 159. Merck Sterile Injectable Drugs Market Share (2018-2020)
Figure 160. GlaxoSmithKline Sterile Injectable Drugs Market Share (2018-2020)
Figure 161. GILEAD SCIENCES Sterile Injectable Drugs Market Share (2018-2020)
Figure 162. Novartis Sterile Injectable Drugs Market Share (2018-2020)
Figure 163. Johnson & Johnson Services Sterile Injectable Drugs Market Share (2018-2020)
Figure 164. Pfizer Sterile Injectable Drugs Market Share (2018-2020)


★調査レポート[世界の無菌注射剤市場予測 2020年-2025年] (コード:LPI21MA11872)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の無菌注射剤市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆